5705-0473 Screening compound: N,N-diethyl-4-[1-(4-methylbenzenesulfonyl)-3-(morpholine-4-carbonyl)imidazolidin-2-yl]aniline

5705-0473 Screening compound: N,N-diethyl-4-[1-(4-methylbenzenesulfonyl)-3-(morpholine-4-carbonyl)imidazolidin-2-yl]aniline
5705-0473 Screening compound: N,N-diethyl-4-[1-(4-methylbenzenesulfonyl)-3-(morpholine-4-carbonyl)imidazolidin-2-yl]aniline alternative view

Chemical Structure Depiction of ChemDiv screening compound 5705-0473
N,N-diethyl-4-[1-(4-methylbenzenesulfonyl)-3-(morpholine-4-carbonyl)imidazolidin-2-yl]aniline

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

5705-0473

Molecular Formula

C25H34N4O4S (C25 H34 N4 O4 S)

Compound Name

N,N-diethyl-4-[1-(4-methylbenzenesulfonyl)-3-(morpholine-4-carbonyl)imidazolidin-2-yl]aniline

IUPAC name

NN-diethyl-4-[1-(4-methylbenzenesulfonyl)-3-(morpholine-4-carbonyl)imidazolidin-2-yl]aniline

SMILES

CCN(CC)c1ccc(C(N(CC2)C(N3CCOCC3)=O)N2S(c2ccc(C)cc2)(=O)=O)cc1

InChI

InChI=1S/C25H34N4O4S/c1-4-26(5-2)22-10-8-21(9-11-22)24-28(25(30)27-16-18-33-19-17-27)14-15-29(24)34(31,32)23-12-6-20(3)7-13-23/h6-13,24H,4-5,14-19H2,1-3H3/t24-/m0/s1

InChI Key

BNTHZLHXWLVFTK-DEOSSOPVSA-N

MDL Number (MFCD)

MFCD03634572

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

486.64

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.001

Distribution Coefficient, logD

3.665

Water Solubility, LogSw

-3.88

Polar Surface Area

60.869

Acid Dissociation Constant (pKa)

25.90

Base Dissociation Constant (pKb)

7.47

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

48.00

5705-0473 in Drug Discovery

Included in Screening Libraries

Antiviral Annotated Library (21441 compounds)

Human Transcription Factors Annotated Library (5098 compounds)

PI3K-Targeted Library (17255 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with 5705-0473 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 5705-0473?
Check Price and Availability of 5705-0473, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 5705-0473 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 5705-0473
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 5705-0473
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 5705-0473 available by request